2008
DOI: 10.1016/j.ijcard.2008.04.083
|View full text |Cite
|
Sign up to set email alerts
|

Covered stents: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
48
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(48 citation statements)
references
References 49 publications
0
48
0
Order By: Relevance
“…The utilization of covered stents is faster, and more effective, and is considered to be the gold standard in the management of coronary perforation [8]. The incidence of subacute thrombosis and restenosis in the covered stents is relatively higher than in the conventional coronary stents (10.3% versus 3.4%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The utilization of covered stents is faster, and more effective, and is considered to be the gold standard in the management of coronary perforation [8]. The incidence of subacute thrombosis and restenosis in the covered stents is relatively higher than in the conventional coronary stents (10.3% versus 3.4%).…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of subacute thrombosis and restenosis in the covered stents is relatively higher than in the conventional coronary stents (10.3% versus 3.4%). This problem may be related to delayed endothelialization and increases susceptibility to thrombus formation [8], and long-term dual antiplatelet therapy is recommended [9]. According to previous studies, in-stent restenosis occurs with a frequency of approximately 30% within the first six months after implantation, and in most cases was related to edge stenosis (29.8%) [10].…”
Section: Discussionmentioning
confidence: 99%
“…Sluggish or turbulent coronary blood flow with resultant ischemic symptoms can occur regardless of the severity of the associated stenotic lesion. Potential complications that could happen include rupture, tamponade, arterial occlusion, and sudden cardiac death [1].…”
Section: Discussionmentioning
confidence: 99%
“…However, these materials suffers from certain degree of thrombogenicity, poor compliance and low flexibility, hence are not favourable for small calibre coronary covered stent membrane 10 . We have developed and patented a nanocomposite material based on polyhedral oligomeric silsesquioxane and poly(carbonate-urea) urethane (POSS-PCU).…”
Section: Introductionmentioning
confidence: 99%